292 related articles for article (PubMed ID: 28917837)
21. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
Gu L; Tran J; Jiang L; Guo Z
J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680
[TBL] [Abstract][Full Text] [Related]
22. Stabilization of nontoxic Aβ-oligomers: insights into the mechanism of action of hydroxyquinolines in Alzheimer's disease.
Ryan TM; Roberts BR; McColl G; Hare DJ; Doble PA; Li QX; Lind M; Roberts AM; Mertens HD; Kirby N; Pham CL; Hinds MG; Adlard PA; Barnham KJ; Curtain CC; Masters CL
J Neurosci; 2015 Feb; 35(7):2871-84. PubMed ID: 25698727
[TBL] [Abstract][Full Text] [Related]
23. Steady-state and time-resolved Thioflavin-T fluorescence can report on morphological differences in amyloid fibrils formed by Aβ(1-40) and Aβ(1-42).
Lindberg DJ; Wranne MS; Gilbert Gatty M; Westerlund F; Esbjörner EK
Biochem Biophys Res Commun; 2015 Mar; 458(2):418-23. PubMed ID: 25660454
[TBL] [Abstract][Full Text] [Related]
24. The binding of apolipoprotein E to oligomers and fibrils of amyloid-β alters the kinetics of amyloid aggregation.
Garai K; Verghese PB; Baban B; Holtzman DM; Frieden C
Biochemistry; 2014 Oct; 53(40):6323-31. PubMed ID: 25207746
[TBL] [Abstract][Full Text] [Related]
25. The neuroprotective peptide NAP inhibits the aggregation of the beta-amyloid peptide.
Ashur-Fabian O; Segal-Ruder Y; Skutelsky E; Brenneman DE; Steingart RA; Giladi E; Gozes I
Peptides; 2003 Sep; 24(9):1413-23. PubMed ID: 14706557
[TBL] [Abstract][Full Text] [Related]
26. Amyloid-beta aggregates formed at polar-nonpolar interfaces differ from amyloid-beta protofibrils produced in aqueous buffers.
Nichols MR; Moss MA; Reed DK; Hoh JH; Rosenberry TL
Microsc Res Tech; 2005 Jul; 67(3-4):164-74. PubMed ID: 16103999
[TBL] [Abstract][Full Text] [Related]
27. Alternate aggregation pathways of the Alzheimer beta-amyloid peptide: Abeta association kinetics at endosomal pH.
Gorman PM; Yip CM; Fraser PE; Chakrabartty A
J Mol Biol; 2003 Jan; 325(4):743-57. PubMed ID: 12507477
[TBL] [Abstract][Full Text] [Related]
28. (R)-α-trifluoromethylalanine containing short peptide in the inhibition of amyloid peptide fibrillation.
Botz A; Gasparik V; Devillers E; Hoffmann AR; Caillon L; Chelain E; Lequin O; Brigaud T; Khemtemourian L
Biopolymers; 2015 Sep; 104(5):601-10. PubMed ID: 25968595
[TBL] [Abstract][Full Text] [Related]
29. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Matsuzaki K
Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
[TBL] [Abstract][Full Text] [Related]
30. In vitro antiaggregation and deaggregation potential of Rhizophora mucronata and its bioactive compound (+)- catechin against Alzheimer's beta amyloid peptide (25-35).
Suganthy N; Sheeja Malar D; Pandima Devi K
Neurol Res; 2016 Dec; 38(12):1041-1051. PubMed ID: 27766923
[TBL] [Abstract][Full Text] [Related]
31. TANGO-Inspired Design of Anti-Amyloid Cyclic Peptides.
Lu X; Brickson CR; Murphy RM
ACS Chem Neurosci; 2016 Sep; 7(9):1264-74. PubMed ID: 27347598
[TBL] [Abstract][Full Text] [Related]
32. Ca(2+) Interacts with Glu-22 of Aβ(1-42) and Phospholipid Bilayers to Accelerate the Aβ(1-42) Aggregation Below the Critical Micelle Concentration.
Yi X; Zhang Y; Gong M; Yu X; Darabedian N; Zheng J; Zhou F
Biochemistry; 2015 Oct; 54(41):6323-32. PubMed ID: 26426973
[TBL] [Abstract][Full Text] [Related]
33. Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation.
Feng Y; Wang XP; Yang SG; Wang YJ; Zhang X; Du XT; Sun XX; Zhao M; Huang L; Liu RT
Neurotoxicology; 2009 Nov; 30(6):986-95. PubMed ID: 19744518
[TBL] [Abstract][Full Text] [Related]
34. Thioflavin T templates amyloid β(1-40) conformation and aggregation pathway.
Di Carlo MG; Minicozzi V; Foderà V; Militello V; Vetri V; Morante S; Leone M
Biophys Chem; 2015 Nov; 206():1-11. PubMed ID: 26100600
[TBL] [Abstract][Full Text] [Related]
35. Curcuminoid binds to amyloid-β1-42 oligomer and fibril.
Yanagisawa D; Taguchi H; Yamamoto A; Shirai N; Hirao K; Tooyama I
J Alzheimers Dis; 2011; 24 Suppl 2():33-42. PubMed ID: 21335654
[TBL] [Abstract][Full Text] [Related]
36. Engineering of a peptide probe for β-amyloid aggregates.
Aoraha E; Candreva J; Kim JR
Mol Biosyst; 2015 Aug; 11(8):2281-9. PubMed ID: 26073444
[TBL] [Abstract][Full Text] [Related]
37. Modulating amyloid-β aggregation: The effects of peptoid side chain placement and chirality.
Turner JP; Chastain SE; Park D; Moss MA; Servoss SL
Bioorg Med Chem; 2017 Jan; 25(1):20-26. PubMed ID: 27776890
[TBL] [Abstract][Full Text] [Related]
38. Amyloid β oligomers induce interleukin-1β production in primary microglia in a cathepsin B- and reactive oxygen species-dependent manner.
Taneo J; Adachi T; Yoshida A; Takayasu K; Takahara K; Inaba K
Biochem Biophys Res Commun; 2015 Mar; 458(3):561-567. PubMed ID: 25680460
[TBL] [Abstract][Full Text] [Related]
39. Insights into the aggregation mechanism of Aβ(25-40).
Xiong J; JiJi RD
Biophys Chem; 2017 Jan; 220():42-48. PubMed ID: 27856006
[TBL] [Abstract][Full Text] [Related]
40. Memantine-sulfur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer's disease.
Sozio P; Cerasa LS; Laserra S; Cacciatore I; Cornacchia C; Di Filippo ES; Fulle S; Fontana A; Di Crescenzo A; Grilli M; Marchi M; Di Stefano A
Eur J Pharm Sci; 2013 May; 49(2):187-98. PubMed ID: 23454012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
